Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 677.00
Bid: 601.00
Ask: 900.00
Change: 0.00 (0.00%)
Spread: 299.00 (49.75%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 677.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Listing and Trading Application

29 Apr 2022 15:15

RNS Number : 9302J
Tate & Lyle PLC
29 April 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

29 April 2022

Tate & Lyle PLC

("Tate & Lyle")

 

Listing and Trading Application

Further to the circular to shareholders published on 7 April 2022 (the "Circular") and the announcement published on 26 April 2022, in connection with the Special Dividend and associated Share Consolidation, Tate & Lyle announces that application has been made to the Financial Conduct Authority for a total of 401,603,808 ordinary shares of 29 1/6 pence each (the "New Ordinary Shares") to be admitted to the premium segment of the Official List and for the New Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities. Although the New Ordinary Shares will have a different nominal value (being 29 1/6 pence each) to the Existing Ordinary Shares, they will be traded on the London Stock Exchange in the same way as the Existing Ordinary Shares and will carry the same rights under the Articles to the Existing Ordinary Shares.

It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 3 May 2022.

The ISIN for the New Ordinary Shares is GB00BP92CJ43.

Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the Circular.

For more information contact:

 

For Tate & Lyle PLC

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, we develop solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

 

We have more than 3,000 employees working in around 60 locations across 30 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31 March 2021, Tate & Lyle's revenue from continuing operations totaled £1.2 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

 

Tate & Lyle's LEI number is: 2138008K14474WPKZ244

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDSIGDDGDC
Date   Source Headline
1st Jul 201912:38 pmRNSTotal Voting Rights
1st Jul 201912:00 pmRNSDirector/PDMR Shareholding
10th Jun 201911:30 amRNSAnnual Financial Report
5th Jun 20199:52 amRNSHolding(s) in Company
5th Jun 20199:34 amRNSDirector/PDMR Shareholding
3rd Jun 201910:42 amRNSTotal Voting Rights
29th May 20194:00 pmRNSDirector/PDMR Shareholding
28th May 20194:12 pmRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSFinal Results
9th May 201911:00 amRNSDirectorate Change
1st May 201910:00 amRNSTotal Voting Rights
1st Apr 20194:17 pmBUSTotal Voting Rights
1st Apr 20193:45 pmBUSHolding(s) in Company
1st Mar 201911:21 amBUSTotal Voting Rights
27th Feb 20191:00 pmBUSHolding(s) in Company
7th Feb 20197:00 amBUSTrading Statement
1st Feb 201911:40 amBUSTotal Voting Rights
3rd Jan 20192:00 pmBUSDirector/PDMR Shareholding
2nd Jan 20193:53 pmBUSBlock listing Interim Review
6th Dec 201811:32 amBUSDirector/PDMR Shareholding
5th Dec 20182:22 pmBUSDirector/PDMR Shareholding
3rd Dec 20183:34 pmBUSTotal Voting Rights
19th Nov 20187:00 amBUSDirectorate change
8th Nov 20187:00 amBUSHalf-year Report
1st Nov 201812:20 pmBUSTotal Voting Rights
5th Oct 20182:05 pmBUSDirector/PDMR Shareholding
1st Oct 20182:25 pmBUSTotal Voting Rights
21st Sep 201811:43 amBUSDirector/PDMR Shareholding
10th Jul 201811:21 amBUSDirector/PDMR Shareholding
10th Jul 201810:50 amBUSHolding(s) in Company
2nd Jul 20183:42 pmBUSTotal Voting Rights
2nd Jul 20183:11 pmBUSBlock listing Interim Review
28th Jun 20185:37 pmBUSDirector/PDMR Shareholding
21st Jun 201812:34 pmBUSAnnual Financial Report
14th Jun 20185:34 pmBUSDirector/PDMR Shareholding
6th Jun 20186:21 pmBUSDirector/PDMR Shareholding
1st Jun 201812:44 pmBUSTotal Voting Rights
29th May 20185:54 pmBUSDirector/PDMR Shareholding
24th May 20187:00 amBUSFinal Results
1st May 20181:00 pmBUSTotal Voting Rights
18th Apr 201812:27 pmBUSDirector/PDMR Shareholding
17th Apr 20187:00 amBUSImran Nawaz Appointed Chief Financial Officer of Tate & Lyle PLC
13th Apr 20181:48 pmBUSDirector Declaration
5th Apr 20184:31 pmBUSDirector/PDMR Shareholding
4th Apr 20184:47 pmBUSDirector/PDMR Shareholding
3rd Apr 201812:27 pmBUSTotal Voting Rights
2nd Mar 201812:04 pmBUSDirector/PDMR Shareholding
15th Feb 20183:44 pmBUSDirector/PDMR Shareholding
14th Feb 20182:55 pmBUSDirector/PDMR Shareholding
13th Feb 20182:03 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.